BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28595541)

  • 1. Association of IL-12 B Gene Polymorphism with Staging of Liver Disease in Chronic HCV Patients.
    Elwan N; Amr K; Elyamany S; Elkhalawany W; Soliman S; Ziada M; Abd-Elsalam S
    Infect Disord Drug Targets; 2018; 18(2):122-128. PubMed ID: 28595541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10 and IL-12p40 in Egyptian patients with HCV-related chronic liver disease.
    Hassoba H; Leheta O; Sayed A; Fahmy H; Fathy A; Abbas F; Attia F; Serwah A
    Egypt J Immunol; 2003; 10(1):1-8. PubMed ID: 15719617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection.
    Youssef SS; Mostafa A; Nasr AS; el Zanaty T; Seif SM
    J Interferon Cytokine Res; 2013 Aug; 33(8):415-9. PubMed ID: 23600862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
    Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
    J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Balasus D; Licata A; Montalto G
    World J Gastroenterol; 2013 Apr; 19(16):2449-55. PubMed ID: 23674845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
    Bouzgarrou N; Hassen E; Schvoerer E; Stoll-Keller F; Bahri O; Gabbouj S; Cheikh I; Maamouri N; Mammi N; Saffar H; Trabelsi A; Triki H; Chouchane L
    J Med Virol; 2008 Apr; 80(4):607-14. PubMed ID: 18297714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals.
    Aroucha DC; Carmo RF; Vasconcelos LR; Lima RE; Mendonça TF; Arnez LE; Cavalcanti Mdo S; Muniz MT; Aroucha ML; Siqueira ER; Pereira LB; Moura P; Pereira LM; Coêlho MR
    J Med Virol; 2016 Sep; 88(9):1587-95. PubMed ID: 26890368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
    Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
    Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma.
    Hetta HF; Zahran AM; Mansor SG; Abdel-Malek MO; Mekky MA; Abbas WA
    J Med Virol; 2019 Jul; 91(7):1319-1328. PubMed ID: 30761547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The -94Ins/DelATTG polymorphism in NFκB1 promoter modulates chronic hepatitis C and liver disease progression.
    Fakhir FZ; Lkhider M; Badre W; Alaoui R; Pineau P; Ezzikouri S; Benjelloun S
    Infect Genet Evol; 2016 Apr; 39():141-146. PubMed ID: 26827631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
    Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
    Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
    World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.